Abstract Title:

Astaxanthin protects against renal fibrosis through inhibiting myofibroblast activation and promoting CD8T cell recruitment.

Abstract Source:

Biochim Biophys Acta Gen Subj. 2019 Jun 3. Epub 2019 Jun 3. PMID: 31170498

Abstract Author(s):

Wenli Diao, Wei Chen, Wenmin Cao, Hui Yuan, Hao Ji, Tianwei Wang, Wei Chen, Xingxing Zhu, Hong Zhou, Hongqian Guo, Xiaozhi Zhao

Article Affiliation:

Wenli Diao


BACKGROUND: Renal fibrosis is a common pathological hallmark of chronic kidney disease, and no effective treatment is clinically available to manage its progression. Astaxanthin was recently found to be anti-fibrotic, but its effect on renal fibrosis remains unclear.

METHODS: C57BL/6J mice were subjected to unilateral ureteral obstruction and intragastrically administered astaxanthin. Histopathology and immunohistochemistry were performed to evaluate renal fibrosis. Flow cytometry was used to examine lymphocyte accumulation in the fibrotic kidneys. Western blotting, real-time qPCR, and immunofluorescence were performed to cover the underlying mechanism concerning astaxanthin treatment during renal fibrosis.

RESULTS: Oral administration of astaxanthin effectively alleviates renal fibrosis in mice. In vitro, astaxanthin inhibited fibroblast activation by modulating Smad2, Akt and STAT3 pathways and suppressed epithelial-to-mesenchymal transition in renal tubular epithelial cells through Smad2, snail, andβ-catenin. Moreover, astaxanthin significantly induced the rapid accumulation of CD8T cells in fibrotic kidneys, which was accompanied by elevated expression of IFN-γ. Accordingly, the depletion of CD8T cells strongly diminished the protective effect of astaxanthin. Further investigation showed that astaxanthin increased the population of CD8T cells by upregulating the expression of CCL5 in macrophages.

CONCLUSIONS: These findings highlight the beneficial effect of astaxanthin on fibroblast activation, epithelial-to-mesenchymal transition, and CD8T cell recruitment during renal fibrosis.

GENERAL SIGNIFICANCE: These data indicate that astaxanthin could serve as a therapeutic strategy to treat renal fibrotic conditions.

Study Type : Animal Study
Additional Links
Pharmacological Actions : Anti-Fibrotic : CK(924) : AC(463)

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.